VBL Therapeutics Announces Appointment of Matthew Trudeau as Chief Commercial Officer

NEXT STORY
Rafael Pharmaceuticals Announces Ongoing Successful Enrollment and Opening of Additional Sites for Phase 2 Clinical Trial of CPI-613® (Devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer
PREV STORY
Worldwide Clinical Trials and Science 37® Partner to Advance Agile Clinical Trials™ and Accelerate Study Timelines
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Calithera Biosciences Appoints Scott Garland to Board of Directors

author_avatar
NASDAQ Market News

ContraFect Announces U.S. FDA Grants Breakthrough Therapy Designation to Exebacase for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia, Including Right-Sided Endocarditis

author_avatar
NASDAQ Market News

Burning Rock to Present Data on Its Early Detection ELSA-seq at ESMO Asia Virtual Congress 2020

author_avatar
NASDAQ Market News